Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2018-11-16 17:56:38
Reporting Period:
Accepted Time:
2018-11-16 17:56:38
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1124105 Catalyst Biosciences Inc. CBIO Pharmaceutical Preparations (2834) 562020050
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1672333 Howard Levy 611 Gateway Boulevard, Suite 710
South San Francisco CA 94080
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-11-16 173 $4.63 7,733 No 4 M Direct
Common Stock Disposition 2018-11-16 173 $11.00 7,560 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2018-11-16 173 $0.00 173 $4.63
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
87,267 2027-07-11 No 4 M Direct
  1. Sale of shares made pursuant to and in accordance with the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, under a plan adopted by the Reporting Person on September 5, 2018.
  2. The Option vests monthly over a period of four years commencing June 15, 2017.